20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
- Canada's health ministry authorized the use of Pfizer Inc (NYSE:PFE) and BioNTech SE's (NASDAQ:BNTX) COVID-19 vaccine as a booster for children 5 - 11 years old at least six months after their initial two doses.-
- The 10 mcg dose was authorized, and this is the first COVID-19 vaccine authorized as a booster dose in this age group.
- The authorization for a booster shot was granted after a thorough, independent review of the vaccine, which provides "an option to restore their child's protection against COVID-19, especially those at high risk of severe illness," the health ministry wrote on Twitter.
- Also Read: Biden Administration To Stop Purchasing COVID-19 Solutions By End Of 2022.
- Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccine is authorized only as a primary series for children 6 - 11 years of age, using a 50 mcg dose, and for children six months to 5 years of age, using a 25 mcg dose.
- Booster doses of Moderna Spikevax (50 mcg) COVID-19 vaccine are authorized only for individuals 18 and older.
- In moderate to severely immunocompromised children, the Canadian authority recommends a primary series of three doses administered at least 4 to 8 weeks apart for both mRNA vaccines.
- Price Action: BNTX shares closed at $147.92, and PFE stock closed at $49.15 on Friday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!